217 related articles for article (PubMed ID: 23401854)
41. The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function.
Koltowska K; Okuda KS; Gloger M; Rondon-Galeano M; Mason E; Xuan J; Dudczig S; Chen H; Arnold H; Skoczylas R; Bower NI; Paterson S; Lagendijk AK; Baillie GJ; Leshchiner I; Simons C; Smith KA; Goessling W; Heath JK; Pearson RB; Sanij E; Schulte-Merker S; Hogan BM
Nat Cell Biol; 2021 Nov; 23(11):1136-1147. PubMed ID: 34750583
[TBL] [Abstract][Full Text] [Related]
42. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.
Binet R; Ythier D; Robles AI; Collado M; Larrieu D; Fonti C; Brambilla E; Brambilla C; Serrano M; Harris CC; Pedeux R
Cancer Res; 2009 Dec; 69(24):9183-91. PubMed ID: 19951988
[TBL] [Abstract][Full Text] [Related]
43. Dhx33 promotes B-cell growth and proliferation by controlling activation-induced rRNA upregulation.
He X; Zhao J; Adilijiang A; Hong P; Chen P; Lin X; Xie J; Du Y; Liu Y; Lin L; Jin HY; Hong Y; Liu WH; Xiao C
Cell Mol Immunol; 2023 Mar; 20(3):277-291. PubMed ID: 36631557
[TBL] [Abstract][Full Text] [Related]
44. Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells.
Halaschek-Wiener J; Wacheck V; Kloog Y; Jansen B
Cell Signal; 2004 Nov; 16(11):1319-27. PubMed ID: 15337531
[TBL] [Abstract][Full Text] [Related]
45. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
[TBL] [Abstract][Full Text] [Related]
46. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin.
Scassa ME; Guberman AS; Varone CL; Cánepa ET
Exp Cell Res; 2001 Dec; 271(2):201-13. PubMed ID: 11716532
[TBL] [Abstract][Full Text] [Related]
47. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.
Apicelli AJ; Maggi LB; Hirbe AC; Miceli AP; Olanich ME; Schulte-Winkeler CL; Saporita AJ; Kuchenreuther M; Sanchez J; Weilbaecher K; Weber JD
Mol Cell Biol; 2008 Feb; 28(3):1068-80. PubMed ID: 18070929
[TBL] [Abstract][Full Text] [Related]
48. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.
Fukawa T; Ono M; Matsuo T; Uehara H; Miki T; Nakamura Y; Kanayama HO; Katagiri T
Cancer Res; 2012 Nov; 72(22):5867-77. PubMed ID: 23019224
[TBL] [Abstract][Full Text] [Related]
49. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB; Willingham MC; Inoue K
Cancer Cell; 2007 Oct; 12(4):381-94. PubMed ID: 17936562
[TBL] [Abstract][Full Text] [Related]
50. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
Bursac S; Brdovcak MC; Donati G; Volarevic S
Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
[TBL] [Abstract][Full Text] [Related]
51. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
Brighenti E; Calabrese C; Liguori G; Giannone FA; Trerè D; Montanaro L; Derenzini M
Oncogene; 2014 Aug; 33(35):4396-406. PubMed ID: 24531714
[TBL] [Abstract][Full Text] [Related]
53. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.
Woods SJ; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2015 Jul; 1849(7):821-9. PubMed ID: 25464032
[TBL] [Abstract][Full Text] [Related]
54. Alternative translation initiation from two in-frame start codons in DHX33 gene.
Wang J; Yuan Z; Zhang Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):501-507. PubMed ID: 29864424
[TBL] [Abstract][Full Text] [Related]
55. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
[TBL] [Abstract][Full Text] [Related]
56. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
57. Function of DHX33 in promoting Warburg effect via regulation of glycolytic genes.
Peng C; Hou ST; Deng CX; Zhang Y
J Cell Physiol; 2021 Feb; 236(2):981-996. PubMed ID: 32617965
[TBL] [Abstract][Full Text] [Related]
58. [DDX5 is a novel targeting protein of tumor suppressor ARF].
Tago K; Funakoshi-Tago M
Seikagaku; 2016 Apr; 88(2):207-10. PubMed ID: 27192872
[No Abstract] [Full Text] [Related]
59. Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
Falcon KT; Watt KEN; Dash S; Zhao R; Sakai D; Moore EL; Fitriasari S; Childers M; Sardiu ME; Swanson S; Tsuchiya D; Unruh J; Bugarinovic G; Li L; Shiang R; Achilleos A; Dixon J; Dixon MJ; Trainor PA
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2116974119. PubMed ID: 35881792
[TBL] [Abstract][Full Text] [Related]
60. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
